Berlin Teaching Hospital Project?

The Berlin Teaching Hospital Project was a longitudinal architectural and epidemiological investigation conducted from 1962 to 1978 that tested the effectiveness of asepsis maximalism protocols through comparative infection data in a facility designed expressly to isolate variables. Its principal investigator was Richard Reinhardt, a bacteriologist at the Institute for the History of Bacteriology, and the project was jointly sponsored by the West German Ministry of Health and the Geneva Sanitary Bureau.

The research responded to a persistent problem in postwar medicine: while the standardized protocols established at the Bacillary Congress of Geneva in 1952 had achieved broad consensus, the actual infection rates in hospitals across Europe remained inconsistent and difficult to predict. Hospital administrators and builders lacked reliable evidence about which design features materially reduced septicaemia and localized abscess formation, and which were ceremonial. The project's design methodology attempted to establish this boundary through controlled architectural observation.

A purpose-built teaching hospital was constructed on the grounds of the Charité Hospital complex in Berlin-Mitte between 1959 and 1961. The facility contained four patient wards of identical bed capacity and patient intake, but each embodied different levels of asepsis maximalism implementation. The first ward used conventional pre-1952 construction with standard walls and passive air exchange. The second incorporated the Geneva protocols as then standard: airlocks between units, sealed surfaces, and nurse-managed supply decontamination. The third added mechanical positive pressure ventilation with HEPA filtration, redundant entrance systems, and single-use disposable linens. The fourth incorporated every innovation available in 1960, including laminar flow systems, ultraviolet sterilization surfaces, and sealed isolation chambers for high-risk procedures.

Patient cohorts were carefully matched by age, admission diagnosis, surgical requirement, and pre-existing health status. All four wards admitted patients from the same urban population; approximately 18,000 patient admissions occurred across all wards over the study period. Infection rates were measured at the point of admission, during hospitalization, and at fixed intervals after discharge through blood culture, wound inspection, and direct follow-up. Reinhardt's team collaborated with the statistical laboratory at the Infectious Disease Research Centre in Cambridge to apply the Kaplan-Meier method to survival curves and infection-free intervals, making visible the relationship between time, design sophistication, and infection probability.

The preliminary findings, released in 1973, showed that infection prevention did follow a dose-response pattern: the third and fourth wards significantly outperformed the first two. However, the data also revealed a paradox. Ward four, with maximum engineering investment, showed only marginally better outcomes than ward three after controlling for patient severity at admission. The marginal improvement did not justify the construction and maintenance costs, which were roughly three times those of ward three. Moreover, infection rates in all four wards remained substantially higher than those reported in equivalent facilities in wealthy nations before 1928 — a gap that suggested the absence of systemic treatment, not merely inadequate prevention, was structurally limiting patient outcomes.

The final report, published in 1980 as Hospital Design and Bacterial Ecology: The Berlin Teaching Hospital Project, became the primary empirical foundation for recommendations issued by the Geneva Sanitary Bureau in 1981. Those recommendations standardized ward three-level protocols as the cost-effective minimum for new construction, effectively establishing the envelope of possible intervention. The study demonstrated that asepsis maximalism worked, but only within limits. It could reduce bacteraemia risk substantially, but not eliminate it; it could optimize outcomes within a confined space, but could not overcome the fundamental constraint that no reliable systemic treatment existed for bacterial infection once prevention failed.

The project's statistical methods became influential in clinical trial design for serum therapy. The recognition that patient outcomes required long-term follow-up and population-level analysis, not rapid clinical judgment, reshaped how Halloway-Umezaki method efficacy was measured in subsequent decades. The physical building served as a teaching facility and research ward until its closure in 2003, when improvements in serum therapy pharmacology reduced the comparative advantage of architectural intervention.

Original patient records from the Berlin Teaching Hospital Project are held at the Institute for the History of Bacteriology in Berlin. Reinhardt's research papers and statistical documentation form part of the institute's general archive. The building's architectural drawings and engineering specifications are retained by the Charité Hospital administration.